Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

Author(s):
Breugom, A.J. (0000-0001-9457-2533); Gijn, W. van; Muller, E.W.; Berglund, A.; Broek, C.B.M. van den; Fokstuen, T.; Gelderblom, H.; Kapiteijn, E.; Leer, J.W.H.; Marijnen, C.A.M. (0000-0003-0189-5953); Martijn, H.; Kranenbarg, E.M.K.; Nagtegaal, I.D.; Pahlman, L.; Punt, C.J.A.; Putter, H.; Roodvoets, A.G.H.; Rutten, H.J.T.; Steup, W.H.; Glimelius, B.; Velde, C.J.H. van de (0000-0003-0104-1800); Dutch Colorectal Canc Grp; Nordic Gastrointestinal Tumour Adj
Published
2015
Publication type
Article / Letter to editor
rectal adenocarcinomaadjuvant chemotherapytotal mesorectal excisionpreoperative radiotherapypreoperative chemoradiotherapy
Date issued
2015-04-30
Language
English
Is part of
Annals of Oncology (2015), Vol. 26, no. 4, p. 696-701
hdl
1887/106685
doi
10.1093/annonc/mdu560